Cost-effectiveness of exercise therapy added to general practitioner care for osteoarthritis of the hip.

Cost-effectiveness of exercise therapy added to general practitioner care for osteoarthritis of the hip. - STERK trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33282

Enrollment

210

Registered

2009-07-03

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aandoeningen aan het bewegingsapparaat Osteoarthritis

Interventions

Participants will be randomised either into the intervention group (receiving exercise therapy by a physiotherapist in addition to GP care) or the control group (receiving GP care only). After admis

advice regarding daily activities, the use of aids, medical treatment and home exercises. The aims of exercise therapy are to improve functioning, to increase levels of activity and participation a

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - consult the GP for a new episode of non-traumatic hip complaints - are 45 years or older - complete the informed consent procedure - comply with the clinical American College of Rheumatology criteria for hip OA (see page 12 of the research protocol)

Exclusion criteria

Exclusion criteria: - already had exercise therapy in the past 3 months. - have hip pain score

Design outcomes

Primary

Measure	Time frame
Main study parameters are hip pain, hip function and direct costs and productivity costs. Hip pain and hip function are measured with the Hip disability Osteoarthritis Outcome Score (HOOS). Direct costs are measured with the modified Trimbos/iMTA Questionnaire for costs (TiC-P) questionnaire. Productivity costs are measured with the Productivity and Disability (PRODISQ) questionnaire. All scores are obtained at baseline and at 6 weeks, 3, 6, 9, 2 months follow-up.	—

Measure

Time frame

Main study parameters are hip pain, hip function and direct costs and productivity costs. Hip pain and hip function are measured with the Hip disability Osteoarthritis Outcome Score (HOOS). Direct costs are measured with the modified Trimbos/iMTA Questionnaire for costs (TiC-P) questionnaire. Productivity costs are measured with the Productivity and Disability (PRODISQ) questionnaire. All scores are obtained at baseline and at 6 weeks, 3, 6, 9, 2 months follow-up.

—

Secondary

Measure	Time frame
Secondary study parameters measured with a questionnaire at baseline and at 6 weeks, 3, 6, 9, 12 months follow-up: - Hip pain, measured with Numeric Rating Scale score (NRS; 0-10 scale). - Hip pain, measured with the Intermittent and Constant Osteoarthritis Pain (ICOAP) questionnaire. - Perceived Recovery, measured with 7-point Likert scale. - Quality of life, measured with EuroQol, EQ-5D. Secondary study parameter measured with a physical examination at baseline and at 12 months follow-up: - Functional mobility, measured with timed Up and Go test.	—

Measure

Time frame

Secondary study parameters measured with a questionnaire at baseline and at 6 weeks, 3, 6, 9, 12 months follow-up: - Hip pain, measured with Numeric Rating Scale score (NRS; 0-10 scale). - Hip pain, measured with the Intermittent and Constant Osteoarthritis Pain (ICOAP) questionnaire. - Perceived Recovery, measured with 7-point Likert scale. - Quality of life, measured with EuroQol, EQ-5D. Secondary study parameter measured with a physical examination at baseline and at 12 months follow-up: - Functional mobility, measured with timed Up and Go test.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)